Theressa Creighton

Theressa Creighton is the Associate Director, Clinical Operations at ILiAD bringing more than a decade of Clinical Operations experience. Her clinical research career started in academia at the University of Pennsylvania. After moving to Boston, she transitioned to the industry at Takeda’s Vaccine Business Unit and most recently managed a first-in-human immune tolerance study in Multiple Sclerosis for a small biotech company. Theressa attended St. John’s College, Annapolis, and has a bachelor’s degree from Arizona State University.